Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Am J Med Genet A. 2017 Dec 8;176(4):842–861. doi: 10.1002/ajmg.a.38494

Table I.

HD Diagnostic Criteria

Genetically Confirmed NOT Genetically Confirmed
Presymptomatic
  • No clinical motor signs or symptoms (Motor DCL = 0 or 1)

  • No cognitive signs or symptoms

  • May or may not have changes in imaging, quantitative motor assessments, or biomarkers

  • No symptomatic treatment indicated

  • Disease-modifying treatment when safe and available

Clinically At-Risk
Prodromal HD
  • Subtle motor signs (Motor DCL = 2)

  • AND/OR subtle cognitive signs or symptoms

  • Apathy, depression or other behavioral changes related to HD may be present

  • Usually changes in imaging and quantitative motor assessments

  • May need symptomatic treatment

  • Disease-modifying treatment appropriate

Clinically Prodromal HD
Manifest HD
  • Presence of clinical motor AND/OR cognitive signs and symptoms that have an impact on life

  • Functional changes, eg, decrease in TFC

  • Motor DCL = 3 or 4 (or Motor DCL of 2 if cognitive changes are significant AND there is evidence of progression)

  • Symptomatic treatment appropriate

  • Disease-modifying treatment appropriate

Clinically Manifest (requires Motor DCL = 4 and cognitive changes)

DCL = diagnostic confidence level; TFC = Total Functional Capacity scale